• Print

released: 11 Nov 2011 author: AIHW media release

Around 170,000 treatment episodes for alcohol and other drug use were provided in Australia in 2009-10. Almost half were for treatment related to alcohol use-the highest proportion observed since the collection began in 2001. As with previous years, counselling was the most common type of treatment offered. One in ten episodes involved more than one type of treatment.

ISSN 1447-6746; ISBN 978-1-74249-224-7; Cat. no. HSE 114; 150pp.; Internet only

Publication

Publication table of contents

  • Preliminary material
    • Title and verso pages
    • Contents
    • Acknowledgments
    • Abbreviations
    • Symbols
    • A summary of alcohol and other drug treatment in 2009–10
  • Body section
    • 1 Introduction
      • Definitions of terms used in this report
      • 1.1 How are the data collected?
      • 1.2 What's included?
        • 1.2.1 Agencies and clients included
        • 1.2.2 Agencies and clients excluded
      • 1.3 Important issues that explain the data
        • 1.3.1 Clients are not counted
        • 1.3.2 Funding source cannot be differentiated
        • 1.3.3 Covering of Indigenous substance use services is limited
        • 1.3.4 Implementation makes a difference
      • 1.4 Data issues specific to the 2009–10 year
      • 1.5 Explanatory notes
    • 2 Treatment agencies–what sector and where are the treatment agencies?
      • 2.1 Service sector
      • 2.2 Locations
      • 2.3 Treatment types reporting from different geographical locations
    • 3 Clients – who uses alcohol and other drug treatment services?
      • 3.1 Own or other's drug use
        • 3.1.1 Across Australia
        • 3.1.2 Age and sex
      • 3.2 Indigenous Australians
        • 3.2.1 Indigenous clients in the AODTS-NMDS collection
        • 3.2.2 Care provided by OATSIH-funded substance use-specific services
      • 3.3 Country of birth and preferred language
    • 4 Drugs of concern–what drugs do people seek treatment for?
      • 4.1 Principal drugs of concern
        • 4.1.1 Principal drugs of concern across Australia
        • 4.1.2 Principal drugs of concern over time
        • 4.1.3 Age and principal drug of concern
        • 4.1.4 Sex and principal drugs of concern
        • 4.1.5 Indigenous Australians and principal drug of concern
      • 4.2 Individual principal drug of concern profiles
        • 4.2.1 Alcohol
          • Patterns of use in Australia
          • Drug profile
          • Client profile
          • Treatment profile
        • 4.2.2 Cannabis
          • Patterns of use in Australia
          • Drug profile
          • Client profile
          • Treatment profile
        • 4.2.3 Heroin
          • Patterns of use in Australia
          • Drug profile
          • Client profile
          • Treatment profile
        • 4.2.4 Amphetamines
          • Patterns of use in Australia
          • Drug profile
          • Client profile
          • Treatment profile
        • 4.2.5 Benzodiazepines
          • Patterns of use in Australia
          • Drug profile
          • Client profile
          • Treatment profile
        • 4.2.6 Ecstasy
          • Patterns of use in Australia
          • Drug profile
          • Client profile
          • Treatment profile
        • 4.2.7 Cocaine
          • Patterns of use in Australia
          • Drug profile
          • Client profile
          • Treatment profile
      • 4.3 All drugs of concern
    • 5 Treatment – what treatments do people receive?
      • 5.1 Main treatment
        • 5.1.1 Main treatment types across Australia
        • 5.1.2 Main treatment types over time
        • 5.1.3 Aboriginal and Torres Strait Islander people and treatment programs
        • 5.1.4 Reasons for leaving treatment
      • 5.2 Specific main treatment types
        • 5.2.1 Counselling
          • Principal drug profile
          • Client profile
          • Treatment profile
        • 5.2.2 Withdrawal management (detoxification)
          • Principal drug profile
          • Client profile
          • Treatment profile
        • 5.2.3 Assessment only
          • Principal drug profile
          • Client profile
          • Treatment profile
        • 5.2.4 Information and education only
          • Principal drug profile
          • Client profile
          • Treatment profile
        • 5.2.5 Support and case management only
          • Principal drug profile
          • Client profile
          • Treatment profile
        • 5.2.6 Rehabilitation
          • Principal drug profile
          • Client profile
          • Treatment profile
        • 5.2.7 Other main treatment types
          • Principal drug profile
          • Client profile
          • Treatment profile
      • 5.3 Additional treatments
      • 5.4 National Opioid Pharmacotherapy Statistics Annual Data Collection 2010
        • 5.4.1 Number of clients receiving pharmacotherapy treatment
      • 5.5 Opioid pharmacotherapy treatment in prison health services 2010
    • 6 Hospital treatment – what drug-related diagnoses do people go to hospital for?
      • 6.1 Drug-related hospital separations in 2009–10
        • 6.1.1 Drugs associated with hospital separations
        • 6.1.2 Hospital separations by sex
        • 6.1.3
        • 6.1.3 Hospital separations by age
        • 6.1.4 Hospital separations by socioeconomic status
        • 6.1.5 Hospital separations among Indigenous Australians
        • 6.1.6 Public versus private hospitals
      • 6.2 Hospital separation trends
    • 7 Collection methods and data quality – how are the data collected?
      • 7.1 Collection method and data included
      • 7.2 Comprehensiveness of the data
        • 7.2.1 Australian Government data
        • 7.2.2 Data quality
      • 7.3 Policy and administrative features in each jurisdiction
      • 7.4 Data quality considerations for other collections
  • End matter
    • Appendix 1: About the collection
      • Responsibility for the collection
      • Government health authorities
      • Alcohol and other drug treatment agencies
      • AIHW
      • Using AODTS–NMDS Data
    • Appendix 2: Data elements in the AODTS NMDS for 2009–10
    • Appendix 3: Detailed tables
      • Agency tables
      • Client profile tables
      • Drugs of concern tables
      • Treatment program tables
      • Hospital separation tables
    • Appendix 4: Australian Standard Geographical Classification
    • Appendix 5: Australian Standard Classification of Drugs of Concern (ASCDC)
      • 1 ANALGESICS
        • 11 Organic Opiate Analgesics
        • 12 Semisynthetic Opioid Analgesics
        • 13 Synthetic Opioid Analgesics
        • 14 Non Opioid Analgesics
      • 2 SEDATIVES AND HYPNOTICS
        • 21 Alcohols
        • 22 Anaesthetics
        • 23 Barbiturates
        • 24 Benzodiazepines
        • 29 Other Sedatives and Hypnotics
      • 3 STIMULANTS AND HALLUCINOGENS
        • 31 Amphetamines
        • 32 Cannabinoids
        • 33 Ephedra Alkaloids
        • 34 Phenethylamines
        • 35 Tryptamines
        • 36 Volatile Nitrates
        • 39 Other Stimulants and Hallucinogens
      • 4 ANABOLIC AGENTS AND SELECTED HORMONES
        • 41 Anabolic Androgenic Steroids
        • 42 Beta Agonists
        • 43 Peptide Hormones, Mimetics and Analogues
        • 49 Other Anabolic Agents and Selected Hormones
      • 5 ANTIDEPRESSANTS AND ANTIPSYCHOTICS
        • 51 Monoamine Oxidase Inhibitors
        • 52 Phenothiazines
        • 53 Serotonin Reuptake Inhibitors
        • 54 Thioxanthenes
        • 55 Tricyclic Antidepressants
        • 59 Other Antidepressants and Antipsychotics
      • 6 VOLATILE SOLVENTS
        • 61 Aliphatic Hydrocarbons
        • 62 Aromatic Hydrocarbons
        • 63 Halogenated Hydrocarbons
        • 69 Other Volatile Solvents
      • 9 MISCELLANEOUS DRUGS OF CONCERN
        • 91 Diuretics
        • 92 Opioid Antagonists
        • 99 Other Drugs of Concern
    • Appendix 6: Alcohol and other drug treatment provided by services funded to assist Aboriginal and Torres Strait Islander people
      • Substance use-specific services
        • Substance use treatment and assistance
          • Substances as a specifically targeted program
          • Substances on an individual client basis
    • Appendix 7: Mapping of ICD-10-AM codes to ASCDC output categories
    • References
    • List of tables
    • List of figures
    • List of boxes

Recommended citation

AIHW 2011. Alcohol and other drug treatment services in Australia 2009-10: report on the National Minimum Data Set. Drug treatment series no. 14. Cat. no. HSE 114. Canberra: AIHW. Viewed 26 October 2014 <http://www.aihw.gov.au/publication-detail/?id=10737420496>.